Prevención con restricción del flujo sanguíneo sobre la incidencia de toxicidad neural en cáncer de mama (PRESIONA): ensayo clínico controlado y aleatorizado durante quimioterapia neoadyuvante
Year: 2023
Type: dissertation
Abstract: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity for many \ncommonly used anticancer agents. It is generated by axonal and dorsal root ganglion \ndamage, predominately is a sensory neuropathy and may influence survival and quality \nof life. Physical exercise programs appear to be feasible and effective at reducing CIPN \nsymptoms. However, in fact, so far CIPN treatment still no cure and lacks robust evidence \nboth for pharmacological and non-pharmacological. Thus, the impact of CIPN has led \nresearchers and clinicians to question which dose of physical exercise is more suitable \nin patients with cancer for prevention of CIPN. This Doctoral Thesis aims to contextualise \nthe state-of-the-art of physical exercise to prevent CIPN in patients with cancer (Study \nI) and to propose a physical exercise program plus blood flow restriction (BFR) with the \ncapacity to prevent neuropathy (PRESIONA) (Study II). \nFor Study I, a systematic review with meta-analysis was carried out to analyze the \neffects of physical exercise applied before or during chemotherapy to prevent or \nameliorate CIPN in randomized controlled trials. Medline, Web of Science, Scopus, and \nCochrane Library were searched. Two reviewers blinded and independent found eight \nstudies (a total of 618 patients with cancer). None of the studies achieved a “low” overall \nrisk of bias. Four studies were included in meta-analysis for quality of life, and a \nsignificance standardized mean difference was found between groups from baseline of \n14.62; 95% CI, 6.03-3.20, with a large effect size g=0.83; 95% CI, 0.48-1.18) in favor of physical exercise program compared with usual care. Physical exercise at the onset of \nchemotherapy has shown promising effects on the prevention of CIPN, specially \nimproving quality of life. However, the diagnosis of CIPN is not avoided with the proposed \nphysical exercise programs in all patients; the severity of symptoms can be reduced. For \nthat reason, looking to the evidence of the physiological potential of BFR plus physical \nexercise on other disorders, it is proposed analysing the effects of PRESIONA (Study II) \nto prevent CIPN in women with early breast cancer undergoing neoadjuvant \nchemotherapy. PRESIONA will be a physical therapist-led multimodal exercise program \nthat uses BFR during low-load aerobic and strength exercises. Feasibility will be \nquantified and in the efficacy study, the main outcome will be EORTC QLQ-CIPN20. The \ninnovative approach of this study could have a far-reaching impact on therapeutic \noptions, and the physical therapist role could be essential in the oncology unit to improve \nquality of life in individuals with cancer and reduce side effects of cancer and its \ntreatments.
Author: López Garzón, María de la Cabeza
Institution: Universidad de Granada
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7005231770
